Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
SN

Smith & Nephew plc

SNLSEUnited KingdomHealthcareMedical DevicesFTSE 100

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

P/E20.27xP/B2.32xROIC8.3%Dividend yield2.6%
£9.25B
Market Cap
EV: £12.07B
MOM5
QUAL7
VAL7
RSK3
SN
£9.25B
Market Cap · EV £12.07B

Smith & Nephew plc

MOM5
QUAL7
VAL7
RSK3

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It…more

Latest RNS from Smith & Nephew plc

Analyst consensus: Hold

As of 22 Jul 2026, 17 analysts rate Smith & Nephew plc a Hold, with 41% buy ratings and a mean price target of 1,367p (range 1,191p–1,552p), +22% vs the current price.

Strong buy: 3Buy: 4Hold: 10Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 1,680p against a current price of 1,119p (+50%), based on EV/EBITDA.

More Healthcare companies